Description
A GCGR antagonist (IC50s = 55 and 56 nM for the human and rat receptors, respectively); inhibits glucagon-induced adenylate cyclase activity (Ki = 254 nM); reduces glucagon-induced increases in blood glucose levels in rats at 3 mg/kg i.v.
Formal name: N-[4-[[[trans-4-(1,1-dimethylethyl)cyclohexyl][[[4-(trifluoromethoxy)phenyl]amino]carbonyl]amino]methyl]benzoyl]-β-alanine
Synonyms:
Molecular weight: 563.6
CAS: 307983-31-9
Purity: ≥98%
Formulation: A crystalline solid